标题
Regulation and Role of EZH2 in Cancer
作者
关键词
-
出版物
Cancer Research and Treatment
Volume 46, Issue 3, Pages 209-222
出版商
Korean Cancer Association
发表日期
2014-07-15
DOI
10.4143/crt.2014.46.3.209
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 3-Deazaneplanocin A (DZNep), an Inhibitor ofS-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation
- (2014) Tohru Fujiwara et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- microRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer
- (2014) Liming Xie et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
- (2014) S. K. Knutson et al. MOLECULAR CANCER THERAPEUTICS
- Jarid2 Is Implicated in the Initial Xist-Induced Targeting of PRC2 to the Inactive X Chromosome
- (2014) Simão Teixeira da Rocha et al. MOLECULAR CELL
- Interactions between JARID2 and Noncoding RNAs Regulate PRC2 Recruitment to Chromatin
- (2014) Syuzo Kaneko et al. MOLECULAR CELL
- O-GlcNAcylation regulates EZH2 protein stability and function
- (2014) C.-S. Chu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EZH2 expands breast stem cells through activation of NOTCH1 signaling
- (2014) M. E. Gonzalez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epigenetic Reprogramming of HOXC10 in Endocrine-Resistant Breast Cancer
- (2014) T. N. Pathiraja et al. Science Translational Medicine
- Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression
- (2013) Lin Zhu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Suppression of tumorigenicity by MicroRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme
- (2013) Shuwei Qiu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer
- (2013) Wang He et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity
- (2013) J. Yan et al. BLOOD
- EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
- (2013) Wendy Béguelin et al. CANCER CELL
- Sox4 Is a Master Regulator of Epithelial-Mesenchymal Transition by Controlling Ezh2 Expression and Epigenetic Reprogramming
- (2013) Neha Tiwari et al. CANCER CELL
- Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
- (2013) Sebastian Bender et al. CANCER CELL
- Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
- (2013) Eunhee Kim et al. CANCER CELL
- Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression
- (2013) Ming Luo et al. CANCER LETTERS
- Sorafenib suppresses growth and survival of hepatoma cells by accelerating degradation of enhancer of zeste homolog 2
- (2013) Shanshan Wang et al. CANCER SCIENCE
- Polycomb repressive complex 2 contributes to DNA double-strand break repair
- (2013) Stuart Campbell et al. CELL CYCLE
- MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer
- (2013) Huijun Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non-Small Cell Lung Carcinoma
- (2013) C. Behrens et al. CLINICAL CANCER RESEARCH
- BRCA1 is a negative modulator of the PRC2 complex
- (2013) Lan Wang et al. EMBO JOURNAL
- Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke
- (2013) Yung-Luen Yu et al. EMBO Molecular Medicine
- E2f6-mediated repression of the meioticStag3andSmc1βgenes during early embryonic development requires Ezh2 and not the de novo methyltransferase Dnmt3b
- (2013) Milena Leseva et al. Epigenetics
- miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling
- (2013) Yuwen Guo et al. FEBS Journal
- The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
- (2013) K.-M. Chan et al. GENES & DEVELOPMENT
- c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma
- (2013) Lei Wang et al. HEPATOLOGY
- Physical Interaction between MYCN Oncogene and Polycomb Repressive Complex 2 (PRC2) in Neuroblastoma
- (2013) Daisy Corvetta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders
- (2013) Tomoya Muto et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Retracted: Role of STAT3 and vitamin D receptor inEZH2-mediated invasion of human colorectal cancer
- (2013) Yan-Wei Lin et al. JOURNAL OF PATHOLOGY
- NF-YA Underlies EZH2 Upregulation and Is Essential for Proliferation of Human Epithelial Ovarian Cancer Cells
- (2013) Azat Garipov et al. MOLECULAR CANCER RESEARCH
- PAF and EZH2 Induce Wnt/β-Catenin Signaling Hyperactivation
- (2013) Hae-Yun Jung et al. MOLECULAR CELL
- EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
- (2013) Jia Shen et al. NATURE
- EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia
- (2013) Jiali Li et al. NATURE NEUROSCIENCE
- Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2
- (2013) N K Mukhopadhyay et al. ONCOGENE
- CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor
- (2013) L Wu et al. ONCOGENE
- Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy
- (2013) W. W. Hwang-Verslues et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
- (2013) P. W. Lewis et al. SCIENCE
- Enhancer of zeste homolog 2 activates wnt signaling through downregulating CXXC finger protein 4
- (2013) H Lu et al. Cell Death & Disease
- The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation
- (2012) Irene Marchesi et al. CELL CYCLE
- Inner workings and regulatory inputs that control Polycomb repressive complex 2
- (2012) M. Maggie O’Meara et al. CHROMOSOMA
- Dysregulation of the Repressive H3K27 Trimethylation Mark in Head and Neck Squamous Cell Carcinoma Contributes to Dysregulated Squamous Differentiation
- (2012) O. M. Gannon et al. CLINICAL CANCER RESEARCH
- Superior Efficacy of a Combined Epigenetic Therapy against Human Mantle Cell Lymphoma Cells
- (2012) W. Fiskus et al. CLINICAL CANCER RESEARCH
- A687V EZH2 is a gain-of-function mutation found in lymphoma patients
- (2012) Christina R. Majer et al. FEBS LETTERS
- PRC2 directly methylates GATA4 and represses its transcriptional activity
- (2012) A. He et al. GENES & DEVELOPMENT
- A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia
- (2012) C. Simon et al. GENES & DEVELOPMENT
- EZH2 couples pancreatic regeneration to neoplastic progression
- (2012) J. Mallen-St. Clair et al. GENES & DEVELOPMENT
- Targeting the enhancer of zeste homologue 2 in medulloblastoma
- (2012) Irina Alimova et al. INTERNATIONAL JOURNAL OF CANCER
- Hypermethylated in Cancer 1 (HIC1) Recruits Polycomb Repressive Complex 2 (PRC2) to a Subset of Its Target Genes through Interaction with Human Polycomb-like (hPCL) Proteins
- (2012) Gaylor Boulay et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Down-Regulation of the miR-25 and miR-30d Contributes to the Development of Anaplastic Thyroid Carcinoma Targeting the Polycomb Protein EZH2
- (2012) Francesco Esposito et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- miR-137 Inhibits the Invasion of Melanoma Cells through Downregulation of Multiple Oncogenic Target Genes
- (2012) Chonglin Luo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Twist-1 Induces Ezh2 Recruitment Regulating Histone Methylation along the Ink4A/Arf Locus in Mesenchymal Stem Cells
- (2012) D. Cakouros et al. MOLECULAR AND CELLULAR BIOLOGY
- MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma
- (2012) Sheng-Dong Huang et al. Molecular Cancer
- Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells
- (2012) A. Avan et al. MOLECULAR CANCER THERAPEUTICS
- EZH2 Generates a Methyl Degron that Is Recognized by the DCAF1/DDB1/CUL4 E3 Ubiquitin Ligase Complex
- (2012) Ji Min Lee et al. MOLECULAR CELL
- Characterization of the EZH2-MMSET Histone Methyltransferase Regulatory Axis in Cancer
- (2012) Irfan A. Asangani et al. MOLECULAR CELL
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
- (2012) Sarah K Knutson et al. Nature Chemical Biology
- Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
- (2012) Panagiotis Ntziachristos et al. NATURE MEDICINE
- Intronic RNAs mediate EZH2 regulation of epigenetic targets
- (2012) Sònia Guil et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- NIPP1 maintains EZH2 phosphorylation and promoter occupancy at proliferation-related target genes
- (2012) Nikki Minnebo et al. NUCLEIC ACIDS RESEARCH
- A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma
- (2012) Y Yang et al. ONCOGENE
- HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer
- (2012) K Kim et al. ONCOGENE
- Expression of EZH2 in renal cell carcinoma as a novel prognostic marker
- (2012) Hye Won Lee et al. PATHOLOGY INTERNATIONAL
- The Role of EZH2 in the Regulation of the Activity of Matrix Metalloproteinases in Prostate Cancer Cells
- (2012) Yong Jae Shin et al. PLoS One
- Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM
- (2012) Dejuan Kong et al. PLoS One
- MiR-214 Targets β-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma
- (2012) Hongping Xia et al. PLoS One
- Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)
- (2012) M. T. McCabe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
- (2012) W. Qi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AS1DHRS4, a head-to-head natural antisense transcript, silences the DHRS4 gene cluster in cis and trans
- (2012) Q. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex
- (2012) Zhijian Duan et al. PROSTATE
- EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
- (2012) K. Xu et al. SCIENCE
- PRAJA1 is a ubiquitin ligase for the polycomb repressive complex 2 proteins
- (2011) Muhammad Zoabi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-138 suppresses epithelial–mesenchymal transition in squamous cell carcinoma cell lines
- (2011) Xiqiang Liu et al. BIOCHEMICAL JOURNAL
- FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells
- (2011) Juan Du et al. BREAST CANCER RESEARCH AND TREATMENT
- Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression
- (2011) Sharon Hensley Alford et al. BREAST CANCER RESEARCH AND TREATMENT
- Coordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer
- (2011) Qi Cao et al. CANCER CELL
- EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling
- (2011) Chun-Ju Chang et al. CANCER CELL
- EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR
- (2011) C. Wang et al. CANCER RESEARCH
- EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes -Catenin-Dependent Hepatocarcinogenesis
- (2011) A. S. L. Cheng et al. CANCER RESEARCH
- MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2
- (2011) J. Lu et al. CANCER RESEARCH
- Histone Methyltransferase EZH2 Induces Akt-Dependent Genomic Instability and BRCA1 Inhibition in Breast Cancer
- (2011) M. E. Gonzalez et al. CANCER RESEARCH
- Long Noncoding RNA HOTAIR Regulates Polycomb-Dependent Chromatin Modification and Is Associated with Poor Prognosis in Colorectal Cancers
- (2011) R. Kogo et al. CANCER RESEARCH
- Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression
- (2011) B. Bao et al. CANCER RESEARCH
- Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy
- (2011) C. D. Kemp et al. CLINICAL CANCER RESEARCH
- The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2
- (2011) Fang Zheng et al. GUT
- Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans
- (2011) Fu Yang et al. HEPATOLOGY
- Cyclin-dependent Kinase 1 (CDK1)-mediated Phosphorylation of Enhancer of Zeste 2 (Ezh2) Regulates Its Stability
- (2011) Susan C. Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interruption of intrachromosomal looping by CCCTC binding factor decoy proteins abrogates genomic imprinting of human insulin-like growth factor II
- (2011) He Zhang et al. JOURNAL OF CELL BIOLOGY
- MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2
- (2011) Ji-guang Zhang et al. Journal of Thoracic Oncology
- Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer
- (2011) Francesco Crea et al. Molecular Cancer
- Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma
- (2011) Cheng Wang et al. MOLECULAR CARCINOGENESIS
- Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
- (2011) Shuet Theng Lee et al. MOLECULAR CELL
- Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression
- (2011) John R Prensner et al. NATURE BIOTECHNOLOGY
- The long noncoding RNA Six3OS acts in trans to regulate retinal development by modulating Six3 activity
- (2011) Nicole A Rapicavoli et al. Neural Development
- The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma
- (2011) R Banerjee et al. ONCOGENE
- MEK–ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes
- (2011) S Fujii et al. ONCOGENE
- Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer
- (2011) H Taniguchi et al. ONCOGENE
- Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101 and miR-98
- (2011) N M Alajez et al. Cell Death & Disease
- S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition
- (2010) Annette Hayden et al. BREAST CANCER RESEARCH AND TREATMENT
- Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
- (2010) Sha Hu et al. CANCER BIOLOGY & THERAPY
- Regulation of Tumor Angiogenesis by EZH2
- (2010) Chunhua Lu et al. CANCER CELL
- ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells through Control of B-Myb and EZH2
- (2010) E. V. Kalashnikova et al. CANCER RESEARCH
- EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo
- (2010) Jianfeng Guo et al. CANCER SCIENCE
- EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β1 and is a predictor of outcome in ovarian carcinoma patients
- (2010) Zhi-Yue Rao et al. CARCINOGENESIS
- Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer
- (2010) B. Zhang et al. CARCINOGENESIS
- TNF/p38α/Polycomb Signaling to Pax7 Locus in Satellite Cells Links Inflammation to the Epigenetic Control of Muscle Regeneration
- (2010) Daniela Palacios et al. Cell Stem Cell
- MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion
- (2010) Hui-Ju Wang et al. EUROPEAN JOURNAL OF CANCER
- Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells
- (2010) Wen-Feng Hua et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA
- (2010) S. Kaneko et al. GENES & DEVELOPMENT
- Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis
- (2010) Dominic J. Ciavatta et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical significance of Polycomb gene expression in brain tumors
- (2010) Francesco Crea et al. Molecular Cancer
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
- (2010) Rajnish A. Gupta et al. NATURE
- CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells
- (2010) Yongkun Wei et al. NATURE CELL BIOLOGY
- Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2
- (2010) Shuai Chen et al. NATURE CELL BIOLOGY
- Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
- (2010) Gorica Nikoloski et al. NATURE GENETICS
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- (2010) Thomas Ernst et al. NATURE GENETICS
- An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB
- (2010) Junxia Min et al. NATURE MEDICINE
- BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients
- (2010) D D De Carvalho et al. ONCOGENE
- The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer
- (2010) J Yu et al. ONCOGENE
- ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer
- (2010) Paolo Kunderfranco et al. PLoS One
- Polycomb Target Genes Are Silenced in Multiple Myeloma
- (2010) Antonia Kalushkova et al. PLoS One
- Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
- (2010) C. J. Sneeringer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
- (2010) M.-C. Tsai et al. SCIENCE
- Polycomb group protein-mediated repression of transcription
- (2010) Lluís Morey et al. TRENDS IN BIOCHEMICAL SCIENCES
- Targeted Overexpression of EZH2 in the Mammary Gland Disrupts Ductal Morphogenesis and Causes Epithelial Hyperplasia
- (2009) Xin Li et al. AMERICAN JOURNAL OF PATHOLOGY
- The Putative Tumor Suppressor microRNA-101 Modulates the Cancer Epigenome by Repressing the Polycomb Group Protein EZH2
- (2009) J. M. Friedman et al. CANCER RESEARCH
- EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
- (2009) M.-L. Suva et al. CANCER RESEARCH
- Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells
- (2009) Manjari Dimri et al. CARCINOGENESIS
- Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem Cells
- (2009) Elena Ezhkova et al. CELL
- Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression
- (2009) Z L Wu et al. CELL DEATH AND DIFFERENTIATION
- Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
- (2009) F. Sun et al. MOLECULAR CANCER THERAPEUTICS
- Mechanisms of Polycomb gene silencing: knowns and unknowns
- (2009) Jeffrey A. Simon et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
- (2009) G. H. S. Richter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
- (2008) S. Sander et al. BLOOD
- Epigenetic-Mediated Dysfunction of the Bone Morphogenetic Protein Pathway Inhibits Differentiation of Glioblastoma-Initiating Cells
- (2008) Jeongwu Lee et al. CANCER CELL
- Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells
- (2008) Satoshi Fujii et al. CANCER SCIENCE
- Regulation of Pancreatic Tumor Cell Proliferation and Chemoresistance by the Histone Methyltransferase Enhancer of Zeste Homologue 2
- (2008) A. V. Ougolkov et al. CLINICAL CANCER RESEARCH
- Enhancer of Zeste Homologue 2 (EZH2) Down-regulates RUNX3 by Increasing Histone H3 Methylation
- (2008) Satoshi Fujii et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Over-expression of polycomb group protein EZH2 relates to decreased expression of p16INK4a in cholangiocarcinogenesis in hepatolithiasis
- (2008) M Sasaki et al. JOURNAL OF PATHOLOGY
- Repression of E-cadherin by the polycomb group protein EZH2 in cancer
- (2008) Q Cao et al. ONCOGENE
- Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1
- (2008) M E Gonzalez et al. ONCOGENE
- The Polycomb Repressive Complex 2 Is a Potential Target of SUMO Modifications
- (2008) Eva Madi Riising et al. PLoS One
- MicroRNA-directed transcriptional gene silencing in mammalian cells
- (2008) D. H. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
- (2008) S. Varambally et al. SCIENCE
- Polycomb Proteins Targeted by a Short Repeat RNA to the Mouse X Chromosome
- (2008) J. Zhao et al. SCIENCE
- The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells
- (2007) R.J. Bryant et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now